Value of the central sensitisation inventory in patients with axial spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/39467633/

Higher levels of physical activity are associated with less evasive coping, better physical function and quality of life in patients with axial spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/38758932/

Patients’ Perspectives on Axial Pain in Relation to Inflammation and Structural Damage in a Large Cohort of Axial Spondyloarthritis Patients (2024)
https://pubmed.ncbi.nlm.nih.gov/37781730/

The mSQUASH is a feasible and valid measurement tool to uniformly assess daily physical activity in patients with rheumatic diseases (2024)
https://pubmed.ncbi.nlm.nih.gov/39448204/

Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study (2023)
https://pubmed.ncbi.nlm.nih.gov/37523038/

Central sensitization has major impact on quality of life in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35033996/

Differences in characteristics, health status and fulfillment of exercise recommendations between axial spondyloarthritis patients with and without supervised group exercise (2022)
https://pubmed.ncbi.nlm.nih.gov/35661547/

Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33492397/

The mSQUASH; a valid, reliable and responsive questionnaire for daily physical activity in patients with axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34144381/